The US is the only OECD country without some form of universal health coverage, resulting in the US spending twice as much (per capita) than other OECD countries.
Despite this higher spending, most data shows health outcomes in the U.S. to be worse than other OECD countries, even after adjusting for nuances like above-average obesity.
Addresses a huge inefficiency in the current medical market - drug affordability. The product helps regular people save an average of 70% off retail pharmacy cash prices. In turn, this helps people get access to medication that would otherwise be out of reach.
Market leader in the space and is primed to take share in their primary markets.